JUDY KY: Open Payments
NPI 1942309463 · LEES SUMMIT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,585 in 109 payments from 16 companies in 2025. Trend: 2023 $859 · 2024 $1,817 · 2025 $2,585
Food & beverage: $2,486Education: $99
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 20 | $470 |
| Janssen Biotech, Inc. | 14 | $393 |
| ABBVIE INC. | 15 | $358 |
| LEO Pharma Inc. | 3 | $253 |
| E.R. Squibb & Sons, L.L.C. | 18 | $203 |
| Novartis Pharmaceuticals Corporation | 4 | $177 |
| Amgen Inc. | 8 | $150 |
| UCB, Inc. | 5 | $115 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $101 |
| Regeneron Healthcare Solutions, Inc. | 3 | $88 |
Products named: NEMLUVIO, TREMFYA, SKYRIZI, Sotyktu, OTEZLA, RINVOQ, Rhapsido, Bimzelx.
Industry payments across MO — which companies pay providers there.
